|
|
|
Insider
Information: |
Vaughn James J |
Relationship: |
Chief Commercial Officer |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genomic Health Inc |
GHDX |
Chief Commercial Officer |
2019-11-08 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2018-11-08 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
20,542 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2018-12-06 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
20,763 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-01-08 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
20,763 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-01-17 |
4 |
OE |
$27.00 |
$63,854 |
D/D |
2,222 |
19,985 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-02-07 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
27,125 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-02-19 |
4 |
OE |
$27.00 |
$36,130 |
D/D |
1,195 |
25,320 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-03-07 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
25,790 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-04-08 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
26,164 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-05-08 |
4 |
OE |
$31.12 |
$140,040 |
D/D |
4,500 |
27,664 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-06-06 |
4 |
OE |
$31.12 |
$140,040 |
D/D |
4,500 |
24,920 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-07-08 |
4 |
OE |
$31.12 |
$140,040 |
D/D |
4,500 |
20,917 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-08-08 |
4 |
OE |
$31.12 |
$142,345 |
D/D |
4,500 |
20,917 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-09-09 |
4 |
OE |
$31.12 |
$143,175 |
D/D |
4,500 |
20,917 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Commercial Officer |
|
2019-10-08 |
4 |
OE |
$33.21 |
$149,445 |
D/D |
4,500 |
20,917 |
0 |
- |
|
64 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|